Aico Worldwide
↗Boston, USA
Aico Worldwide (also known as AICO Global) is a Boston-based digital health company that provides an AI-first agentic system for clinical trial operations. The company specializes in integrating multi-agent AI systems into the clinical trial lifecycle to automate manual, error-prone tasks and streamline fragmented tools. Their platform is designed to boost patient enrollment and reduce overall trial timelines by up to 50%.
Founded by a team of clinical development and AI experts, Aico focuses on 'agentic AI'—autonomous AI agents that can execute complex workflows within clinical research. The company is a member of the Nvidia Inception program and is actively scaling its technology for use by biotech and pharmaceutical companies globally.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:
Industry:Digital Health
Sub-Industry:Clinical Trial Automation
SIZE & FINANCIALS
Employees:1-50
Revenue:Early Stage
Founded:2025
Ownership:private
Status:operating
FUNDING
Stage:Seed
Investors:Nvidia Inception Program
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Technology Platform)
Modalities:Small molecule, mAb, Cell therapy, Gene therapy
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Nvidia (Inception Program member), TriHealth (Clinical trial operations collaboration via co-founder background)
COMPETITION
Position:Emerging
Competitors:Tempus AI, Medable, Deep 6 AI, Paradigm, QuantHealth
LEADERSHIP
Key Executives:
Xiaomin Chen - CEO
Samantha Mallahan - Cofounder
David Lew - Clinical Operations Expert
Scientific Founders:Samantha Mallahan
LINKS
Website:aicoworldwide.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Aico Worldwide. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.